Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04284059Phase 4Unknown
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) (3 arms). Primary endpoint: Vanderbilt Assessment Scale at 8 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04284059.